SEARCH

SEARCH BY CITATION

References

  • ALBASAN, H., SOLDANI, G. & BROWN, D.R. (1999). Synthetic cannabinoids potentiate electrically-induced contractions in porcine ileum in vitro. Pharm. Res., 39, (Supplement) 5.
  • CALIGNANO, A., LA RANA, G., MAKRIAYANNIS, A., LIN, S.Y., BELTRAMO, M. & PIOMELLI, D. (1997). Inhibition of intestinal motility by anandamide, an endogenous cannabinoid. Eur. J. Pharmacol., 340, R7R8.
  • CHESHER, G.B., DAHL, C.J., EVERNGHAM, M., JACKSON, D.M., MARCHANT-WILLIAMS, H. & STARMER, G.A. (1973). The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice. Br. J. Pharmacol., 49, 588594.
  • COLOMBO, G., AGABIO, R., LOBINA, C., REALI, R. & GESSA, G.L. (1998). Cannabinoid modulation of intestinal propulsion in mice. Eur. J. Pharmacol., 344, 6769.
  • COMPTON, D.R., GOLD, L.H., WARD, S.J., BALSTER, R.L. & MARTIN, B.R. (1992). Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from Δ9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther., 263, 11181126.
  • COUTTS, A.A. & PERTWEE, R.G. (1997). Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus. Br. J. Pharmacol., 121, 15571566.
  • CROCI, T., MANARA, L., AUREGGI, G., GUAGNINI, F., RINALDI-CARMONA, M., MAFFRAND, J.P., LE FUR, G., MUKENGE, S. & FERLA, G. (1998). In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum. Br. J. Pharmacol., 125, 13931396.
  • DEVANE, W.A., HANUS, L., BREUER, A., PERTWEE, R.G., STEVENSON, L.A., GRIFFIN, G., GIBSON, D., MANDELBAUM, A., ETINGER, A. & MECHOULAM, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 277, 119131.
  • DEWEY, W.L., HARRIS, L.S. & KENNEDY, J.S. (1972). Some pharmacological and toxicological effects of 1-trans-8 and 1-trans-9tetrahydrocannabinol in laboratory rodents. Arch. Int. Pharmacod. Ther., 196, 133145.
  • FELDER, C.C. & GLASS, M. (1998). Cannabinoid receptors and their endogenous agonists. Annu. Rev. Pharmacol. Toxicol., 38, 179200.
  • GRIFFIN, G., FERNANDO, S.R., ROSS, R.A., MCKAY, N.G., ASHFORD, M.L.J., SHIRE, D., HUFFMAN, J.W., YU, S., LAINTON, J.A.H. & PERTWEE, R.G. (1997). Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals. Eur. J. Pharmacol., 339, 5361.
  • HALEY, T.J. & MCCROMICK, W.G. (1957). Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol., 12, 1215.
  • HEINEMANN, A., SHAHBAZIAN, A. & HOLZER, P. (1999). Cannabinoid inhibition of guinea-pig intestinal peristalsis via inhibition of excitatory and activation of inhibitory neural pathways. Neuropharmacology, 38, 12891297.
  • IZZO, A.A., MASCOLO, N., BORRELLI, F. & CAPASSO, F. (1998). Excitatory transmission to the circular muscle of the guinea-pig ileum: evidence for the involvement of cannabinoid CB1 receptor. Br. J. Pharmacol., 124, 13631368.
  • IZZO, A.A., MASCOLO, N., BORRELLI, F. & CAPASSO, F. (1999a). Defaecation, intestinal fluid accumulation and motility in rodents: implications of cannabinoid CB1 receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 359, 6570.
  • IZZO, A.A., MASCOLO, N., CAPASSO, R., GERMANO', M.P., DE PASQUALE, R. & CAPASSO, F. (1999b). Inhibitory effect of cannabinoid agonists on gastric emptying in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol., 360, 221223.
  • IZZO, A.A., MASCOLO, N., PINTO, L., CAPASSO, R. & CAPASSO, F. (1999c). The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats. Eur. J. Pharmacol., 384, 3742.
  • IZZO, A.A., MASCOLO, N., TONINI, M. & CAPASSO, F. (2000). Modulation of peristalsis by cannabinoid CB1 ligands in the isolated guinea-pig ileum. Br. J. Pharmacol., 129, 984990.
  • JACKSON, D.M., MALOR, R., CHESHER, G.B., STARMER, G.A., WELBURN, P.J. & BAILEY, R. (1976). The interaction between prostaglandin E1 and delta9-tetrahydrocannabinol on intestinal motility and on the abdominal constriction response in the mouse. Psychopharmacology, 47, 187193.
  • LANDSMAN, R.S., BURKEY, T.H., CONSROE, P., ROESKE, W.R. & YAMAMURA, H.I. (1997). SR141716A is an inverse agonist at the human cannabinoid CB1 receptors. Eur. J. Pharmacol., 334, R1R2.
  • LOPEZ-REDONDO, F., LEES, G.M. & PERTWEE, R.G. (1997). Effects of cannabinoid receptor ligands on electrophysiological properties of myenteric neurones of the guinea-pig ileum. Br. J. Pharmacol., 122, 330384.
  • MACLENNAN, S.L., REYNEN, P.H., KWAN, J. & BONHAUS, D.W. (1998). Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors. Br J. Pharmacol., 124, 619622.
  • MATSUDA, L.A., LOLAIT, S.J., BROWNSTEIN, B.J., YOUNG, A.C. & BONNER, T.L. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561564.
  • MECHOULAM, R., BEN-SHABAT, S., HANUS, L., LIGUMSKY, M., KAMINSKI, N.E., SCHATZ, A.R., GOPHER, A., ALMOG, S., MARTIN, B.R., COMPTON, D.R., PERTWEE, R.G., GRIFFIN, G., BAYEWITCH, M., BARG, J. & VOGEL, Z. (1995). Identification of an endogenous 2-monogliceride, present in canine gut, that binds to a cannabinoid receptor. Biochem. Pharmacol., 50, 8390.
  • MECHOULAM, R., FRIDE, E. & DI MARZO, V. (1998). Endocannabinoids. Eur. J. Pharmacol., 359, 118.
  • MUNRO, S., THOMAS, K.L. & ABU-SHAAR, M. (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365, 6165.
  • PERTWEE, R.G. (1998). Pharmacological, physiological and clinical implications of the discovery of cannabinoid receptors. Biochem. Soc. Trans., 26, 267272.
  • PERTWEE, R.G., FERNANDO, S.R., NASH, J.E. & COUTTS, A.A. (1996). Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine. Br. J. Pharmacol., 118, 21992205.
  • PETITET, F., JEANTAUD, B., REIBAUD, M., IMPERATO, A. & DUBROEUCQ, M.C. (1998). Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of Δ9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors. Life Sci., 63, PL1PL6.
  • POL, O., VALLE, L., FERRER, I. & PUIG, M. (1996). The inhibitory effects of α2-adrenoceptor agonists on gastrointestinal transit during croton oil-induced intestinal inflammation. Br. J. Pharmacol., 119, 16491655.
  • RINALDI-CARMONA, M., BARTH, F., HEAULME, M., ALFONSO, R., SHIRE, D., CONGY, C., SOBRIE', P., BRELIERE, J.-C. & LE FUR, G. (1995). Biochemical and pharmacological characterization of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci., 56, 19411947.
  • RINALDI-CARMONA, M., BARTH, F., MILLAN, J., DEROCQ, J.M., CASELLAS, P., CONGY, C., OUSTRIC, D., SARRAN, M., BOUABOULA, M., CALANDRA, B., PORTIER, M., SHIRE, D., BRELIERE, J.C. & LE FUR, G. (1998). SR144528, the first potent and selective antagonist of the CB2 cannabinoid receptors. J. Pharmacol. Exp. Ther., 284, 644650.
  • SCHIRGI-DEGEN, A. & BEUBLER, E. (1995). Significance of nitric oxide in the stimulation of intestinal fluid absorption in the rat jejunum in vivo. Br. J. Pharmacol., 114, 1318.
  • SHOOK, J.E. & BURKS, T.F. (1989). Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents. J. Pharmacol. Exp. Ther., 249, 444449.
  • STELLA, N., SCHWEITZER, P. & PIOMELLI, D. (1997). A second endogenous cannabinoid that modulates long-term potentiation. Nature, 388, 773778.
  • TALLARIDA, R.J. & MURRAY, R.B. (1986). Manual of Pharmacological Calculations with Computer Programs. New York: Springer-Verlag.